PlainRecalls
FDA Drug Moderate Class II Terminated

Mefloquine HCL Tablets, 250 mg, 5 tablets per blister pack; 5 Blister packs per carton, Rx only, Teva Pharmaceuticals USA Sellersville, PA 18960, Individual blister pack: NDC 0555-0171-88, 25 Unit-Dose Tablets (5x5) Carton: NDC 0555-0171-78

Reported: July 4, 2012 Initiated: April 2, 2012 #D-1396-2012

Product Description

Mefloquine HCL Tablets, 250 mg, 5 tablets per blister pack; 5 Blister packs per carton, Rx only, Teva Pharmaceuticals USA Sellersville, PA 18960, Individual blister pack: NDC 0555-0171-88, 25 Unit-Dose Tablets (5x5) Carton: NDC 0555-0171-78

Reason for Recall

Tablet Thickness: Product is being recalled due to the potential of being underweight or overweight.

Details

Units Affected
4188 cartons (5 X 5 blisterpacks)
Distribution
Nationwide
Location
Sellersville, PA

Frequently Asked Questions

What product was recalled?
Mefloquine HCL Tablets, 250 mg, 5 tablets per blister pack; 5 Blister packs per carton, Rx only, Teva Pharmaceuticals USA Sellersville, PA 18960, Individual blister pack: NDC 0555-0171-88, 25 Unit-Dose Tablets (5x5) Carton: NDC 0555-0171-78. Recalled by Teva Pharmaceuticals USA, Inc.. Units affected: 4188 cartons (5 X 5 blisterpacks).
Why was this product recalled?
Tablet Thickness: Product is being recalled due to the potential of being underweight or overweight.
Which agency issued this recall?
This recall was issued by the FDA Drug on July 4, 2012. Severity: Moderate. Recall number: D-1396-2012.